Floatz logo

Sgn-Alpv

Testicular Neoplasms

Seagen Inc.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Testicular Neoplasms cohort.

Asset / SponsorPhaseRating
Pembrolizumab
Nasser Hanna, M.D.
Phase 2CCC
Interleukin-1
National Cancer Institute (NCI)
Phase 1CC

Same molecule, other indications

Sgn-Alpv is also rated in:

gastroesophageal junction adenocarcinomaDormant
CC
Indicative ·
43 / 100
View asset →
gastric neoplasmDormant
CC
Indicative ·
41 / 100
View asset →
uterine cervix neoplasmDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →